Molecular Templates, Inc.

( )
THLD PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. -4.97%136.250.0%$893.93m
AMGNAmgen, Inc. 1.12%247.501.5%$828.95m
GILDGilead Sciences, Inc. 0.90%63.841.0%$542.01m
VRTXVertex Pharmaceuticals, Inc. 1.23%258.591.9%$461.95m
REGNRegeneron Pharmaceuticals, Inc. 0.61%661.142.6%$422.10m
ILMNIllumina, Inc. 1.14%243.493.3%$313.80m
NVAXNovavax, Inc. -8.57%53.4275.7%$307.51m
BIIBBiogen, Inc. 3.40%199.651.8%$240.05m
BNTXBioNTech SE -2.90%163.000.0%$226.41m
SNSSSunesis Pharmaceuticals, Inc. 1.93%2.110.7%$147.50m
EXASEXACT Sciences Corp. -1.54%53.1717.7%$147.09m
TXG10X Genomics, Inc. 0.58%50.160.0%$101.29m
TECHBio-Techne Corp. -0.03%366.354.5%$100.80m
NKTXNkarta, Inc. -1.78%12.670.0%$99.26m
BMRNBioMarin Pharmaceutical, Inc. 0.56%79.724.2%$98.40m

Company Profile

Molecular Templates, Inc. engages in the discovery, development, and commercialization of biologic therapeutics for the treatment of cancers and other serious diseases. It utilizes its proprietary biologic drug platform to design and generate engineered toxin bodies, or ETBs. The company was founded by Eric E. Poma, Jean Gariépy, and Leigh Revers in 2000 and is headquartered in Austin, TX.